A study published in JAMA Network Open investigated the relationship between seizure duration during electroconvulsive therapy (ECT) and remission rates in patients with major depressive disorder (MDD). The study analyzed data from 6998 patients treated between 2012 and 2019 in Sweden. The primary outcome was remission, defined as a score of less than 10 on the self-assessment version of the Montgomery-Asberg Depression Rating Scale (MADRS-S) within one week after ECT. The study found that patients with seizure durations of 60-69 seconds had the highest remission rates compared to those with shorter durations. Patients with seizure durations of less than 20 seconds had the lowest remission rates. The study also found that the use of anticonvulsant medications, such as lamotrigine and benzodiazepines, was associated with shorter seizure durations and lower remission rates. Additionally, higher electrical charges were associated with higher remission rates and shorter seizure durations. The study concluded that seizure duration is associated with ECT outcomes, with longer durations linked to better treatment outcomes. However, the use of anticonvulsant medications during ECT was associated with shorter seizure durations and lower remission rates. The study highlights the importance of seizure duration in ECT treatment and the potential impact of concurrent medication use on treatment outcomes.A study published in JAMA Network Open investigated the relationship between seizure duration during electroconvulsive therapy (ECT) and remission rates in patients with major depressive disorder (MDD). The study analyzed data from 6998 patients treated between 2012 and 2019 in Sweden. The primary outcome was remission, defined as a score of less than 10 on the self-assessment version of the Montgomery-Asberg Depression Rating Scale (MADRS-S) within one week after ECT. The study found that patients with seizure durations of 60-69 seconds had the highest remission rates compared to those with shorter durations. Patients with seizure durations of less than 20 seconds had the lowest remission rates. The study also found that the use of anticonvulsant medications, such as lamotrigine and benzodiazepines, was associated with shorter seizure durations and lower remission rates. Additionally, higher electrical charges were associated with higher remission rates and shorter seizure durations. The study concluded that seizure duration is associated with ECT outcomes, with longer durations linked to better treatment outcomes. However, the use of anticonvulsant medications during ECT was associated with shorter seizure durations and lower remission rates. The study highlights the importance of seizure duration in ECT treatment and the potential impact of concurrent medication use on treatment outcomes.